PredictImmune Gains CE-IVD Mark for IBD Test

Dec 11, 2018

|

NEW YORK (GenomeWeb) – PredictImmune has obtained a CE-IVD mark for its debut test for inflammatory bowel disease, the company said today.

By achieving certification for the test, called PredictSure IBD, the Cambridge, UK-based firm can sell it for clinical use across Europe and other geographies that recognize the designation.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Cleared the Committee

The Washington Post reports that a US Senate committee voted this week to approve the nomination of Stephen Hahn to lead the Food and Drug Administration.

Hope, But Cost Worries

Nature News reports that gene therapy approaches are tackling sickle cell disease, but that the cost of treatment is a concern.

One Gene to Shape the Face

One gene regulates hundreds of others to influence facial development, according to New Scientist.

Nature Studies Review Resources for Single-Cell Analysis, Examine ALS Exomes, More

In Nature this week: resources for single-cell analysis, little overlap in the microRNAs used by Salmonella and Shigella to infect host cells, and more.

Featured White Papers

Orthogonal Methods for Validation and Confirmation of Next-Generation Sequencing Results

Sample Normalization with RNAGEM

RNAGEM - mRNA Profiles as Close to Biological Reality as Possible

High-throughput Miniaturized Quantitative PCR with the Echo 525 Liquid Handler

Dec

17

Featured Webinar

Non-Invasive Characterization of Solid Tumors via NGS Liquid Biopsy Testing

This webinar will review how liquid biopsy can be considered as an alternative and non-invasive method to tissue biopsy for cancer molecular characterization.

Jan

28

Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Menu

PredictImmune Gains CE-IVD Mark for IBD Test

To read the full story....

Breaking News

Veritas Genetics Halts US Operations

New Products Posted to GenomeWeb: Quadrant Biosciences, InterVenn Biosciences, Macrogen, More

Childhood Kidney Cancer Arises From Altered Normal Tissue, Sequencing Study Finds

Amgen Gifts $1M to Keck Graduate Institute for Genomics Education Center

Ancestors of Sub-Saharan Africans Interbred With Archaic Humans

Centogene Q3 Revenues Decrease 13 Percent Due to Non-Recurring Payments From Pharma Partners

The Scan

Cleared the Committee

Hope, But Cost Worries

One Gene to Shape the Face

Nature Studies Review Resources for Single-Cell Analysis, Examine ALS Exomes, More

Featured White Papers

Non-Invasive Characterization of Solid Tumors via NGS Liquid Biopsy Testing

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

What's Popular?

Illumina, ArcherDx Expand Partnership on NGS IVD Tests

UK Researchers Implement Diagnostics.ai System to Improve Infectious Disease Testing

Hologic Vaginitis Tests Offer Improvements Over Gold Standard Methods

Co-Diagnostics Joint Venture Gets Clearance in India for Five MDx Tests

Sponsorships